Clinical Trials Directory

Trials / Completed

CompletedNCT02101723

Effect of Sprinkles With and w/o Fe on Zn Absorption in Kenyan Toddlers

Effects of Sprinkles With and Without Iron on Zinc Absorption From Local Foods in Kenyan Toddlers, Including the Gut Microbiome

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
63 (actual)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
All
Age
5 Months – 10 Months
Healthy volunteers
Accepted

Summary

The investigators propose to study the effects of increased iron intake by home fortification of complementary foods on the gastrointestinal microbial development, inflammatory responses, and zinc (Zn) absorption. The proposed subjects are 9 month olds living in a malaria endemic area of rural Kenya who are randomized at 6 months of age to one of three fortificant groups: 1) Sprinkles™ with 12mg Iron(Fe)/day + other micronutrients, including 5mg/d Zn (test); Sprinkles™ with 0 mg/d Fe + other micronutrients, including 5mg/d Zn (control); Sprinkles™ with no micronutrients (placebo). The investigators hypothesize that the microbiome will be significantly different in the three groups and that Zn absorption and status, in addition to immune and oxidant status will be improved in the non-Fe fortified groups when compared to the Fe-fortified group.

Detailed description

Specific aims include exploration of possible mechanisms of adverse events that have been observed in iron supplementation trials in infants in malaria endemic regions by: 1. Characterizing the impact of enteral iron administration on the evolution of the intestinal microbiome in infants from 6 to 9 months of age. 2. Characterizing iron administration-associated inflammatory responses and correlate these with changes in the intestinal microbiome in infants from 6 to 9 months of age. Specifically, changes in the microbiome will be correlated with biomarkers reflecting: 1. Intestinal inflammation; 2. Systemic inflammation, bacterial translocation, and oxidant stress; 3. Iron status and homeostasis 3. Quantify to what degree Fe interferes with Zn absorption (TAZ) and how it affects the size of the infant's exchangeable zinc pool (EZP).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMNP + Zn/FeMicronutrient powder with 12 mg Fe and 5 mg Zn provided daily from 6-9 months of age
DIETARY_SUPPLEMENTMNP + ZnMicronutrient powder with 5 mg Zn provided daily from 6-9 months of age
DIETARY_SUPPLEMENTPlaceboPlacebo powder without micronutrients

Timeline

Start date
2011-04-01
Primary completion
2013-01-01
Completion
2016-02-01
First posted
2014-04-02
Last updated
2018-05-21

Locations

2 sites across 2 countries: United States, Kenya

Source: ClinicalTrials.gov record NCT02101723. Inclusion in this directory is not an endorsement.